uploads///hospital _

How These Medical Equipment Stocks Have Fared in the Last Month


Dec. 6 2018, Updated 1:50 p.m. ET

Align Technology’s price performance

Align Technology (ALGN) stock fell from $245.31 on November 7, 2018, to a low of $204.43 on November 19, 2018. After that, the stock rose to $235.70 on December 3, 2018. However, from a high of $391.52 on October 1, 2018, the stock has corrected by ~43.6% to its current levels.

Article continues below advertisement

Financial snapshot

Align Technology’s top line has grown by 31.15% from $385.27 million in the third quarter of 2017 to $505.29 million in the third quarter of 2018. The company’s revenue in the fourth quarter of 2018 is expected at $513.43 million. Its gross margins contracted from 75.92% in the third quarter of 2017 to 73.58% in the third quarter of 2018. Further, for fiscal 2018 and 2019, Align’s gross margins are expected at 73.97% and 73.69%, respectively.

From $231.42 million in fiscal 2017, the company’s net income is expected to grow to $396.34 million in fiscal 2018 and $478.58 million in fiscal 2019.

Analysts’ recommendations

In December 2018, of the total 15 analysts covering Align Technology, 13 analysts have given the stock a “buy” or a higher rating, and two analysts have given it a “hold” rating. While the mean rating for Align remains unchanged from November at 1.67, its target price has been lowered to $317.36 in December 2018 as compared with $320.14 in November 2018.

In the next part, we’ll explore the performance of Boston Scientific stock.


More From Market Realist